Home›Stock Screener›Akums Drugs & Pharma›Shareholding Pattern

Akums Drugs & Pharma Shareholding Pattern

As of Jun 2026, Akums Drugs & Pharma (AKUMS) promoter holding 75.26%, FII 1.91%, DII 13.44%, public 5.57%, total shareholders 70,289. For live price, key ratios and the full company profile, see AKUMS screener.

Promoter Holding 75.26%
FII Holding 1.91%
DII Holding 13.44%
Public Holding 5.57%
Total Shareholders 70,289
As of Jun 2026

AKUMS Recent Shareholding Changes — Promoter, FII & DII

Akums Drugs & Pharma promoter, FII and DII holding change from Mar 2026 to Jun 2026, FII +0.54%, DII -0.91%. Browse Akums Drugs & Pharma financial data for revenue, profit, balance sheet and cash flow data.

Promoter Holding Change
Mar 2026 to Jun 2026
No Change
FII Holding Change
Mar 2026 to Jun 2026
+0.54%
DII Holding Change
Mar 2026 to Jun 2026
-0.91%
Public Holding Change
Mar 2026 to Jun 2026
+0.23%

Akums Drugs & Pharma Quarterly Shareholding Trend — Promoter, FII, DII & Public

AKUMS promoter, FII, DII, public and government holding % by quarter — institutional ownership and promoter pledge trends. Explore AKUMS investment value to estimate fundamental worth using multiple valuation models.

Promoter
FII
DII
Public
Government

AKUMS Shareholding Pattern Data — Quarterly History

Akums Drugs & Pharma quarterly promoter, FII, DII, public holding % and total shareholders. Download as Excel or CSV.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Jun 2026 75.26% 1.91% 13.44% 0.00% 5.57% 3.82% 100.00% 70,289
Mar 2026 75.26% 1.37% 14.35% 0.00% 5.34% 3.68% 100.00% 72,589
Dec 2025 75.26% 1.15% 14.40% 0.00% 5.51% 3.68% 100.00% 76,869
Sept 2025 75.26% 2.28% 9.28% 0.00% 5.01% 8.18% 100.01% 75,365
Jun 2025 75.26% 4.24% 8.85% 0.00% 3.60% 8.05% 100.00% 69,424
Mar 2025 75.26% 5.77% 7.40% 0.00% 3.41% 8.16% 100.00% 69,366
Dec 2024 75.26% 6.36% 7.00% 0.00% 3.33% 8.05% 100.00% 68,410
Sept 2024 75.26% 7.34% 7.52% 0.00% 2.11% 7.77% 100.00% 57,531
Aug 2024 75.26% 5.32% 7.60% 0.00% 4.43% 7.38% 99.99% 138,205
Feb 2024 84.91% 0.00% 0.00% 0.00% 0.00% 15.09% 100.00% 8
Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Jun 2026 75.26% 1.91% 13.44% 0.00% 5.57% 3.82% 100.00% 70,289
Mar 2026 75.26% 1.37% 14.35% 0.00% 5.34% 3.68% 100.00% 72,589
Dec 2025 75.26% 1.15% 14.40% 0.00% 5.51% 3.68% 100.00% 76,869
Sept 2025 75.26% 2.28% 9.28% 0.00% 5.01% 8.18% 100.01% 75,365
Jun 2025 75.26% 4.24% 8.85% 0.00% 3.60% 8.05% 100.00% 69,424
Mar 2025 75.26% 5.77% 7.40% 0.00% 3.41% 8.16% 100.00% 69,366
Dec 2024 75.26% 6.36% 7.00% 0.00% 3.33% 8.05% 100.00% 68,410
Sept 2024 75.26% 7.34% 7.52% 0.00% 2.11% 7.77% 100.00% 57,531
Aug 2024 75.26% 5.32% 7.60% 0.00% 4.43% 7.38% 99.99% 138,205
Feb 2024 84.91% 0.00% 0.00% 0.00% 0.00% 15.09% 100.00% 8
Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 75.26% 1.37% 14.35% 0.00% 5.34% 3.68% 100.00% 72,589
Dec 2025 75.26% 1.15% 14.40% 0.00% 5.51% 3.68% 100.00% 76,869
Dec 2024 75.26% 6.36% 7.00% 0.00% 3.33% 8.05% 100.00% 68,410